![Beth Shafer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Beth Shafer
Direttore/Membro del Consiglio presso
Aquinnah Pharmaceuticals, Inc.
Profilo
Currently, Beth Shafer is Director at Aquinnah Pharmaceuticals, Inc. and Venture Partner at Mubadala Capital Ventures Europe.
Formerly, Dr. Shafer was Director at Arcellx, Inc., Chief Business Officer at Voyager Therapeutics, Inc. from 2023 to 2024, and Chief Business Officer at Scholar Rock Holding Corp.
from 2024 to 2025.
Education includes a doctorate from the University of California, graduate studies at Columbia University Vagelos College of Physicians & Surgeons, and undergraduate studies at Rutgers University, Camden.
Posizioni attive di Beth Shafer
| Società | Posizione | Inizio |
|---|---|---|
Aquinnah Pharmaceuticals, Inc.
 Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in research and development to modulate neurodegenerative stress granules | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Beth Shafer
| Società | Posizione | Fine |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Corporate Officer/Principal | 01/05/2025 |
| VOYAGER THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2024 |
| ARCELLX, INC. | Direttore/Membro del Consiglio | - |
Formazione di Beth Shafer
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
12
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Aquinnah Pharmaceuticals, Inc.
Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in research and development to modulate neurodegenerative stress granules | Health Technology |
Rutgers University, Camden
 Rutgers University, Camden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arcellx, Inc.
 Arcellx, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies | Health Technology |
Scholar Rock Holding Corp.
 Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
Columbia University Vagelos College of Physicians & Surgeons
 Columbia University Vagelos College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
